In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Syria Conflict Squeezes Drug Supplies for Major Diseases, WHO Says

This article was originally published in PharmAsia News

Executive Summary

Syria’s local production of medicines, once 90% of the nation’s consumption, has been greatly reduced by the civil war in the country, particularly in the provinces of Aleppo, Damascus and Homs where local drug makers tended to congregate.

You may also be interested in...



2019 Sees Decline In EMA Drug Approval Recommendations

The number of positive opinions given by the EMA’s CHMP has fallen to 66 this year from 84 in 2018.

Concessions Hit And Miss As Some UK Prices Treble

Concession prices granted by the UK Department of Health and Social Care targeted some, but not all, of the fastest-rising generics prices in November. The average cost of some presentations more than trebled, according to the latest figures from WaveData.

Reckitt Targets UK's Painful ‘Tweens’ With Double-Strength Nurofen

Reckitt Benckiser wants to give British parents more pain relief options for their teens and "tweens."

Topics

UsernamePublicRestriction

Register

SC082105

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel